ストックスクリーナーアプリを入手
523.44
1.97%
10.11
アフターアワーズ：
522.90
-0.54
-0.10%
前日終値:
$513.33
開ける：
$518.69
24時間の取引高:
2.32M
Relative Volume:
1.02
時価総額：
$194.52B
収益：
$45.20B
当期純損益:
$6.87B
株価収益率:
28.78
EPS:
18.1888
ネットキャッシュフロー:
$6.75B
1週間 パフォーマンス:
+3.50%
1か月 パフォーマンス:
+8.58%
6か月 パフォーマンス:
-11.66%
1年 パフォーマンス:
+22.37%
1日の値動き範囲:
$511.98
$529.15
1週間の範囲:
$495.10
$529.15
52週間の値動き範囲:
$403.36
$643.99
Thermo Fisher Scientific Inc Stock (TMO) Company Profile
名前
Thermo Fisher Scientific Inc
セクター
電話
(781) 622-1000
住所
168 THIRD AVENUE, WALTHAM, MA
Compare TMO vs DHR, IDXX, NTRA, WAT
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
TMO
Thermo Fisher Scientific Inc
|
523.44 | 186.32B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
197.93 | 134.82B | 24.78B | 3.68B | 5.29B | 5.1743 |
IDXX
Idexx Laboratories Inc
|
557.80 | 41.53B | 4.45B | 1.10B | 1.06B | 13.59 |
NTRA
Natera Inc
|
279.32 | 38.88B | 2.50B | -226.32M | 71.51M | -1.6412 |
WAT
Waters Corp
|
379.29 | 36.82B | 3.77B | 449.25M | 240.68M | 7.8556 |
Thermo Fisher Scientific Inc Stock (TMO) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-03-27 | 開始されました | DZ Bank | Buy |
| 2025-12-11 | アップグレード | Citigroup | Neutral → Buy |
| 2025-12-09 | 開始されました | Goldman | Buy |
| 2025-12-08 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2025-12-02 | 再開されました | Morgan Stanley | Overweight |
| 2025-12-01 | アップグレード | HSBC Securities | Hold → Buy |
| 2025-09-11 | アップグレード | Barclays | Equal Weight → Overweight |
| 2025-08-19 | 開始されました | William Blair | Outperform |
| 2025-07-24 | ダウングレード | HSBC Securities | Buy → Hold |
| 2025-07-11 | アップグレード | Scotiabank | Sector Perform → Sector Outperform |
| 2025-07-09 | ダウングレード | UBS | Buy → Neutral |
| 2025-01-10 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2024-12-23 | 開始されました | Scotiabank | Sector Perform |
| 2024-10-14 | 開始されました | Redburn Atlantic | Buy |
| 2024-10-01 | 開始されました | Stephens | Overweight |
| 2024-08-28 | 開始されました | Wells Fargo | Overweight |
| 2024-06-03 | 再開されました | Jefferies | Buy |
| 2024-03-18 | 再開されました | Citigroup | Neutral |
| 2024-01-24 | ダウングレード | Barclays | Overweight → Equal Weight |
| 2024-01-08 | ダウングレード | Bernstein | Outperform → Mkt Perform |
| 2023-12-18 | 開始されました | HSBC Securities | Buy |
| 2023-12-13 | 開始されました | Wolfe Research | Outperform |
| 2023-10-26 | ダウングレード | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-10-25 | アップグレード | Wells Fargo | Underweight → Equal Weight |
| 2023-09-28 | 開始されました | Bernstein | Outperform |
| 2023-09-06 | 再開されました | Citigroup | Buy |
| 2023-07-19 | 開始されました | Raymond James | Outperform |
| 2023-07-19 | 繰り返されました | Robert W. Baird | Outperform |
| 2023-07-13 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2023-04-04 | 繰り返されました | Barclays | Overweight |
| 2022-12-14 | 開始されました | Deutsche Bank | Buy |
| 2022-12-07 | 開始されました | RBC Capital Mkts | Outperform |
| 2022-10-27 | ダウングレード | The Benchmark Company | Buy → Hold |
| 2022-08-25 | 開始されました | Credit Suisse | Neutral |
| 2022-04-25 | ダウングレード | Wells Fargo | Equal Weight → Underweight |
| 2022-01-26 | 再開されました | Barclays | Overweight |
| 2021-10-20 | アップグレード | Citigroup | Neutral → Buy |
| 2021-10-15 | 再開されました | Cowen | Outperform |
| 2021-08-05 | 再開されました | Credit Suisse | Outperform |
| 2021-07-16 | 開始されました | The Benchmark Company | Buy |
| 2021-03-18 | アップグレード | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-03-03 | 開始されました | Barclays | Overweight |
| 2021-01-08 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-12-02 | 開始されました | Goldman | Buy |
| 2020-11-10 | 開始されました | KeyBanc Capital Markets | Sector Weight |
| 2020-09-30 | 開始されました | Atlantic Equities | Overweight |
| 2020-09-14 | 開始されました | Morgan Stanley | Overweight |
| 2020-08-20 | 再開されました | JP Morgan | Overweight |
| 2020-07-15 | アップグレード | Cleveland Research | Neutral → Buy |
| 2020-07-07 | 繰り返されました | Needham | Buy |
| 2020-04-23 | 繰り返されました | Needham | Buy |
| 2020-01-31 | 繰り返されました | Needham | Buy |
| 2020-01-22 | 開始されました | Credit Suisse | Neutral |
| 2020-01-08 | 開始されました | Wells Fargo | Equal Weight |
| 2020-01-07 | 開始されました | Citigroup | Buy |
| 2019-11-15 | 開始されました | Stifel | Buy |
| 2019-07-25 | 繰り返されました | Needham | Buy |
| 2019-07-16 | ダウングレード | Needham | Strong Buy → Buy |
| 2019-05-30 | 開始されました | Wolfe Research | Outperform |
| 2019-05-23 | 繰り返されました | Needham | Strong Buy |
| 2019-04-22 | 繰り返されました | Needham | Strong Buy |
| 2019-04-16 | 繰り返されました | BofA/Merrill | Buy |
すべてを表示
Thermo Fisher Scientific Inc (TMO) 最新ニュース
Thermo Fisher Scientific Inc. stock rises Wednesday, outperforms market - MarketWatch
Thermo Fisher NanoDrop OneC from Thermo Fisher Scientific Inc.compact UV-Vis spectrophotometer po - AD HOC NEWS
Thermo Fisher Scientific to Hold Earnings Conference Call on Thursday, July 23, 2026 - BioSpace
Form 4 Thermo Fisher Scientific For: 30 June By Investing.com - Investing.com Canada
Thermo Fisher (NYSE: TMO) director awarded new phantom stock units as deferred pay - Stock Titan
Thermo Fisher (TMO) director adds phantom stock units via deferred pay grant - Stock Titan
Thermo Fisher (NYSE: TMO) director awarded new phantom stock units - Stock Titan
Thermo Fisher (NYSE: TMO) director defers fees into phantom stock units - Stock Titan
Thermo Fisher (TMO) director receives phantom stock unit award under deferred plan - Stock Titan
AustinPx Expands KinetiSol™ Technology Commercial Access through Thermo Fisher Scientific Collaboration - 01net
Thermo Fisher Scientific Expands HLA-DQ Testing Coverage for Transplant Antibody Assessment - Clinical Lab Products
Thermo Fisher Scientific Earnings Preview: What to Expect - Barchart.com
Thermo Fisher Scientific Agrees to Buy Clario Holdings for $8.88 Billion - MSN
Thermo Fisher Scientific Inc. stock falls Monday, underperforms market - MarketWatch
Genedrive Teams Up with Thermo Fisher Scientific to Develop Laboratory-based Genetic Test - marketscreener.com
genedrive shares climb 8% on Thermo Fisher pharmacogenetic testing deal - Proactive Investors
Genedrive Partners with Thermo Fisher to Expand CYP2C19 Diagnostic Portfolio (GDR) - Yahoo Finance UK
REGGenedrive PLCCYP2C19 Agreement with Thermo Fisher Scientific - TradingView
Thermo Fisher Scientific: Gradually Getting Cheaper - Seeking Alpha
Oxidative Stress Assay Market Size to Reach USD 3.25 Billion by 2035 | SNS Insider - GlobeNewswire Inc.
Thermo Fisher Scientific Inc.(NYSE: TMO) added to Russell 1000 Dynamic Index - marketscreener.com
Thermo Fisher outlines capital plans for 2030, shares tracked against S&P 500 peers - Ad-hoc-news.de
Thermo Fisher Stock Trades at $513 While Wall Street Sets a $596 Target: What the EPS Ramp Reveals - TIKR.com
Bernstein Says Life Science Sector is Improving, Resumes Thermo Fisher Scientific (TMO) Coverage - Insider Monkey
Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh Actuals & Estimates (BCBA:TMOD) - TradingView
The Axion M200 from Thermo Fisher Scientific Inc.compact microscope for crowded benchtops - Ad-hoc-news.de
Thermo Fisher extends its diagnostics reach, shares supported by strong S&P 500 positioning - Ad-hoc-news.de
Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh Actuals & Estimates (BCBA:TMOC) - TradingView
Thermo Fisher Scientific Inc. stock rises Friday, outperforms market - MarketWatch
Bernstein SocGen resumes Thermo Fisher stock coverage with market perform - Investing.com
Thermo Fisher (TMO) Coverage Resumed with Market Perform Rating and $520 Target - GuruFocus
Thermo Fisher Scientific Inc. Shs Cert Deposito Arg Repr 0.0454545 Sh Actuals & Estimates (BCBA:TMO) - TradingView
Thermo Fisher Scientific (TMO) Stock After Recent Volatility Is The Current Price Reasonable - Yahoo Finance
Thermo Fisher Scientific Inc. stock rises Thursday, outperforms market - MarketWatch
Is Thermo Fisher (TMO) Quietly Redefining Its Edge With AI-Enabled, End-to-End Biopharma Tools? - Yahoo Finance Singapore
Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 3.23% on Jun 25: Key Drivers Unveiled - TradingKey
Thermo Fisher Scientific Inc. Actuals & Estimates (NYSE:TMO) - TradingView
Q1 Earnings Highlights: Thermo Fisher (NYSE:TMO) Vs The Rest Of The Research Tools & Consumables Stocks - Yahoo Finance
Thermo Fisher gains as investors weigh growth targets, Clario integration, and fresh analyst support - Quiver Quantitative
Thermo Fisher Scientific’s Dr Anil Kane Discusses How AI and Strategic Partnerships Are Reshaping Contract Drug Development at BIO 2026 - BioPharm International
Enterprise value to EBIT forward of Thermo Fisher Scientific Inc – NYSE:TMO - TradingView
TMO Forecast — Price Target — Prediction for 2027 - TradingView
Enterprise value to revenue forward of Thermo Fisher Scientific Inc – NYSE:TMO - TradingView
Thermo Fisher breaks through a fresh 52-week high, shares extend the S&P 500 run - Ad-hoc-news.de
Thermo Fisher Scientific (TMO) Showcases AI Tools As Fair Value Narrative Stays In Focus - Sahm
Thermo Fisher Scientific Inc (TMO) Stock Up 4.9% and Still Under - GuruFocus
Thermo Fisher Is Down 27% From Its Highs. The EPS Trough Looks Like It Is Already Behind the Company - TIKR.com
Thermo Fisher Scientific Inc Stock (TMO) Moved Up by 3.84% on Jun 24: What Investors Need To Know - TradingKey
Thermo Fisher (NYSE:TMO) Draws Attention With Expanding AI Strategy - Kalkine Media
Is Thermo Fisher Scientific Inc. (TMO) a Top Life Sciences Tools Stock After New Analyst Coverage? - Insider Monkey
Shapiro Administration Highlights the Need for Funding to Grow Pennsylvania’s Innovation Economy During Visit to Thermo Fisher Scientific in Dauphin County - PA Department of Community & Economic Development (.gov)
Thermo Fisher Scientific Inc (TMO) 財務データ
収益
当期純利益
現金流量
EPS
2.17%
2.02%
大文字化:
|
ボリューム (24 時間):